159 related articles for article (PubMed ID: 38619801)
1. WTAP-mediated N6-methyladenine Modification of circEEF2 Promotes Lung Adenocarcinoma Tumorigenesis by Stabilizing CANT1 in an IGF2BP2-dependent Manner.
Zheng H; Cao Z; Lv Y; Cai X
Mol Biotechnol; 2024 Apr; ():. PubMed ID: 38619801
[TBL] [Abstract][Full Text] [Related]
2. METTL3 facilitates prostate cancer progression via inducing HOXC6 m6A modification and stabilizing its expression through IGF2BP2-dependent mechanisms.
He P; Liu X; Yu G; Wang Y; Wang S; Liu J; An Y
Mol Cell Biochem; 2024 May; ():. PubMed ID: 38822192
[TBL] [Abstract][Full Text] [Related]
3. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
4. FLOT1, stabilized by WTAP/IGF2BP2 mediated N6-methyladenosine modification, predicts poor prognosis and promotes growth and invasion in gliomas.
Song T; Hu Z; Zeng C; Luo H; Liu J
Heliyon; 2023 Jun; 9(6):e16280. PubMed ID: 37260902
[TBL] [Abstract][Full Text] [Related]
5. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
Genomics; 2023 Jan; ():110566. PubMed ID: 36690262
[TBL] [Abstract][Full Text] [Related]
6. The m6A Reader YTHDC2 Suppresses Lung Adenocarcinoma Tumorigenesis by Destabilizing MRPL12.
Sun Y; Liu Y; Wang P; Chang L; Huang J
Mol Biotechnol; 2024 May; 66(5):1051-1061. PubMed ID: 38129673
[TBL] [Abstract][Full Text] [Related]
7. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of UCA1 by N6-methyladenosine RNA methylation modification promotes colorectal cancer progression.
He RZ; Jiang J; Hu X; Lei M; Li J; Luo W; Duan L; Hu Z; Mo YY; Luo DX; Peng WX
Cancer Cell Int; 2021 Nov; 21(1):616. PubMed ID: 34809621
[TBL] [Abstract][Full Text] [Related]
9. WTAP contributes to the tumorigenesis of osteosarcoma via modulating ALB in an m6A-dependent manner.
Pan Q; Lou J; Yan P; Kang X; Li P; Huang Z
Environ Toxicol; 2023 Jun; 38(6):1455-1465. PubMed ID: 36988233
[TBL] [Abstract][Full Text] [Related]
10. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
[TBL] [Abstract][Full Text] [Related]
11. WTAP Mediated the N6-methyladenosine Modification of PDK4 to Regulate the Malignant Behaviors of Colorectal Cancer Cells
Dai X; Chen K; Xie Y
Curr Med Chem; 2023; 30(29):3368-3381. PubMed ID: 36154586
[TBL] [Abstract][Full Text] [Related]
12. WTAP-Involved the m6A Modification of lncRNA FAM83H-AS1 Accelerates the Development of Gastric Cancer.
Liu N; Zhang C; Zhang L
Mol Biotechnol; 2023 Jul; ():. PubMed ID: 37477820
[TBL] [Abstract][Full Text] [Related]
13. m6A Methyltransferase, WTAP, Promotes Cancer Progression in Laryngeal Squamous Cell Carcinoma by Regulating PLAU Stability.
Liu F; Xia F; Wang C; Ren R; Zhang M; Gong J; Zhang Q
Ann Clin Lab Sci; 2023 Mar; 53(2):293-302. PubMed ID: 37094860
[TBL] [Abstract][Full Text] [Related]
14. m6A methyltransferase Wilms' tumor 1-associated protein facilitates cell proliferation and cisplatin resistance in NK/T cell lymphoma by regulating dual-specificity phosphatases 6 expression via m6A RNA methylation.
Ma H; Shen L; Yang H; Gong H; Du X; Li J
IUBMB Life; 2021 Jan; 73(1):108-117. PubMed ID: 33205540
[TBL] [Abstract][Full Text] [Related]
15. WTAP dysregulation-mediated HMGN3-m6A modification inhibited trophoblast invasion in early-onset preeclampsia.
Bian Y; Li J; Shen H; Li Y; Hou Y; Huang L; Song G; Qiao C
FASEB J; 2022 Dec; 36(12):e22617. PubMed ID: 36412513
[TBL] [Abstract][Full Text] [Related]
16. The m6A reader IGF2BP2 promotes the progression of esophageal squamous cell carcinoma cells by increasing the stability of OCT4 mRNA.
Zhao R; Li T; Zhao X; Yang Z; Ma L; Wang X
Biochem Cell Biol; 2024 Apr; 102(2):169-178. PubMed ID: 37917979
[TBL] [Abstract][Full Text] [Related]
17. HNRNPA2B1 inhibited SFRP2 and activated Wnt-β/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.
Rong L; Xu Y; Zhang K; Jin L; Liu X
Pathol Res Pract; 2022 May; 233():153794. PubMed ID: 35364458
[TBL] [Abstract][Full Text] [Related]
18. WTAP activates MAPK signaling through m6A methylation in VEGFA mRNA-mediated by YTHDC1 to promote colorectal cancer development.
Ye M; Chen J; Yu P; Hu C; Wang B; Bao J; Lu F; Zhong Y; Yan L; Kan J; Bai J; Tian Y; Tang Q
FASEB J; 2023 Aug; 37(8):e23090. PubMed ID: 37428639
[TBL] [Abstract][Full Text] [Related]
19. METTL3/IGF2BP2 axis affects the progression of colorectal cancer by regulating m6A modification of STAG3.
Yi J; Peng F; Zhao J; Gong X
Sci Rep; 2023 Oct; 13(1):17292. PubMed ID: 37828232
[TBL] [Abstract][Full Text] [Related]
20. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
Ma Z; Li Q; Liu P; Dong W; Zuo Y
Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]